Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
TTNP > SEC Filings for TTNP > Form 8-K on 22-Mar-2013All Recent SEC Filings

Show all filings for TITAN PHARMACEUTICALS INC

Form 8-K for TITAN PHARMACEUTICALS INC


22-Mar-2013

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On March 21, 2013, Titan Pharmaceuticals, Inc. announced that the majority of the members of the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration (the "FDA") voted in favor of approval of Probuphine for the maintenance treatment of adult patients with opioid dependence. The FDA is not bound by the recommendation of its advisory committee, but will consider the committee's guidance as it evaluates the Probuphine New Drug Application.

The press release dated March 21, 2013 is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release dated March 21, 2013


  Add TTNP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for TTNP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.